Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Trendelenburg Marten

Anti-C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154-mediated inflammation in peripheral blood mononuclear cells in vitro

Rabatscher P.A.; Trendelenburg M.. Clinical and Translational Immunology. 2022.

C1q as a target molecule to treat human disease: What do mouse studies teach us?

Schulz K.; Trendelenburg M.. Frontiers in Immunology. 2022.

Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study.

Bruni F; Charitos P; Lampart M; Moser S; Siegemund M; Bingisser R; Osswald S; Bassetti S; Twerenbold R; Trendelenburg M; Rentsch KM; Osthoff M. Frontiers in Immunology. 2022.

Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis.

Capoferri G; Daikeler T; Mühleisen B; Trendelenburg M; Müller S. Clinics in dermatology. 2022.

Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicenter cohort study.

Breillat P; Jachiet M; Ditchi Y; Lenormand C; Costedoat-Chalumeau N; Mathian A; Moguelet P; Duriez P; Trendelenburg M; Huynh-Do U; Chizzolini C; Beuvon C; Roy-Peaud F; Bouaziz JD; Barbaud A; Francès C; Mékinian A; Fain O; Amoura Z; Chasset F; for EMSED study group (Etude des maladies systémiques en dermatologie) .; Swiss SLE Cohort Study (SSCS) .. Rheumatology (Oxford, England). 2022.

Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus

Kleer J.S.; Rabatscher P.A.; Weiss J.; Leonardi J.; Vogt S.B.; Kieninger-Grafitsch A.; Chizzolini C.; Huynh-Do U.; Ribi C.; Trendelenburg M.. Frontiers in Immunology. 2022.

Perception of physicians and nursing staff members regarding outside versus bedside ward rounds: ancillary analysis of the randomised BEDSIDE-OUTSIDE trial.

Gross S; Beck K; Becker C; Gamp M; Mueller J; Loretz N; Amacher SA; Bohren C; Gaab J; Schuetz P; Mueller B; Fux CA; Leuppi JD; Schaefert R; Langewitz W; Trendelenburg M; Breidthardt T; Eckstein J; Osthoff M; Bassetti S; Hunziker S. Swiss Medical Weekly. 2022.

Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity

Chasset F.; Mathian A.; Dorgham K.; Ribi C.; Trendelenburg M.; Huynh-Do U.; Roux-Lombard P.; Courvoisier D.S.; Amoura Z.; Gorochov G.; Chizzolini C.. Annals of the rheumatic diseases. 2022.

Severe myopathy complicating multisystem inflammatory syndrome in adults (MIS-A) in a young man

Costa A.E.; Bernasconi N.S.; Trendelenburg M.; Schunemann M.J.. BMJ case reports. 2022.

Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression

Urwyler P.; Moser S.; Trendelenburg M.; Sendi P.; Osthoff M.. Molecular immunology. 2022.

Anti-C1q Autoantibodies: Standard Quantification and Innovative ELISA

Csorba K.; Schirmbeck L.; Dubler D.; Trendelenburg M.. . 2021.

Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial.

Vogt S; Leuppi JD; Schuetz P; Mueller B; Volken C; Dräger S; Trendelenburg M; Rutishauser J; Osthoff M. Respiratory research. 2021.

Autoantibodies against complement component C1q in systemic lupus erythematosus

Trendelenburg M.. Clinical and Translational Immunology. 2021.

Effect of bedside compared with outside the room patient case presentation on patients' knowledge about their medical care: A randomized, controlled, multicenter trial

Becker C.; Gamp M.; Schuetz P.; Beck K.; Vincent A.; Hochstrasser S.; Metzger K.; Widmer M.; Thommen E.; Mueller B.; Fux C.A.; Leuppi J.D.; Schaefert R.; Langewitz W.; Trendelenburg M.; Breidthardt T.; Eckstein J.; Osthoff M.; Bassetti S.; Hunziker S.. Annals of internal medicine. 2021.

Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study

Charitos P.; Heijnen I.A.F.M.; Egli A.; Bassetti S.; Trendelenburg M.; Osthoff M.. Frontiers in Immunology. 2021.

Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers

Huebner S.T.; Henny S.; Giezendanner S.; Brack T.; Brutsche M.; Chhajed P.; Clarenbach C.; Dieterle T.; Egli A.; Frey M.; Heijnen I.; Irani S.; Sievi N.A.; Thurnheer R.; Trendelenburg M.; Kohler M.; Leuppi-Taegtmeyer A.B.; Leuppi J.D.. Respiration. 2021.

Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)

Urwyler P.; Charitos P.; Moser S.; Heijnen I.A.F.M.; Trendelenburg M.; Thoma R.; Sumer J.; Camacho-Ortiz A.; Bacci M.R.; Huber L.C.; Stussi-Helbling M.; Albrich W.C.; Sendi P.; Osthoff M.. Trials. 2021.

Variants affecting the C-terminal tail of UNC93B1 are not a common risk factor for systemic lupus erythematosus

Kiener S.; Ribi C.; Keller I.; Chizzolini C.; Trendelenburg M.; Huynh-Do U.; von Kempis J.; Leeb T.. Genes. 2021.

Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus.

Nigolian H; Ribi C; Courvoisier DS; Pagano S; Alvarez M; Trendelenburg M; Huynh-Do U; Vuilleumier N; Dayer JM; Chizzolini C; Roux-Lombard P. Rheumatology (Oxford, England). 2020.

A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury.

Panagiotou A; Trendelenburg M; Heijnen IAFM; Moser S; Bonati LH; Breidthardt T; Fahrni G; Kaiser C; Jeger R; Osthoff M. JACC. Cardiovascular interventions. 2020.

Case Report-Secondary Antibody Deficiency Due to Endogenous Hypercortisolism.

Sarcevic J; Cavelti-Weder C; Berger CT; Trendelenburg M. . 2020.

Complement C1q Enhances Primary Hemostasis.

Donat C; Kölm R; Csorba K; Tuncer E; Tsakiris DA; Trendelenburg M. Frontiers in Immunology. 2020.

Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.

Chasset F; Ribi C; Trendelenburg M; Huynh-Do U; Roux-Lombard P; Courvoisier DS; Chizzolini C; Swiss SLE Cohort Study (SSCS.. Rheumatology (Oxford, England). 2020.

Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases

Vogt S.; Trendelenburg M.; Tamm M.; Stolz D.; Hostettler K.E.; Osthoff M.. Frontiers in Immunology. 2020.

No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus.

Kieninger-Gräfitsch A; Vogt S; Ribi C; Dubler D; Chizzolini C; Huynh-Do U; Osthoff M; Trendelenburg M. . 2020.

Preclinical to clinical translation of cenerimod, a novel S1P<sub>1</sub> receptor modulator, in systemic lupus erythematosus.

Strasser DS; Froidevaux S; Sippel V; Gerossier E; Grieder U; Pierlot GM; Kieninger-Graefitsch A; Vezzali E; Stalder AK; Renault B; Ryge J; Hart A; Mentzel U; Groenen PMA; Keller MP; Trendelenburg M; Martinic MM; Murphy MJ. RMD open. 2020.

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System.

Urwyler P; Moser S; Charitos P; Heijnen IAFM; Rudin M; Sommer G; Giannetti BM; Bassetti S; Sendi P; Trendelenburg M; Osthoff M. Frontiers in Immunology. 2020.

Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.

Csorba K; Schirmbeck LA; Tuncer E; Ribi C; Roux-Lombard P; Chizzolini C; Huynh-Do U; Vanhecke D; Trendelenburg M. Frontiers in Immunology. 2019.

Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus.

Pröbstel AK; Thanei M; Erni B; Lecourt AC; Branco L; André R; Roux-Lombard P; Koenig KF; Huynh-Do U; Ribi C; Chizzolini C; Kappos L; Trendelenburg M; Derfuss T; Swiss Systemic Lupus Erythematosus Cohort Study Group.. Rheumatology (Oxford, England). 2019.

Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages.

Donat C; Thanei S; Trendelenburg M. Frontiers in Immunology. 2019.

Ficolin-3 Deficiency Is Associated with Disease and an Increased Risk of Systemic Lupus Erythematosus.

Troldborg A; Steffensen R; Trendelenburg M; Hauser T; Winther KG; Hansen AG; Stengaard-Pedersen K; Voss A; Thiel S. Journal of clinical immunology. 2019.

Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: A cross-sectional study

Osthoff M.; Jaeger V.K.; Heijnen I.A.F.M.; Trendelenburg M.; Jordan S.; Distler O.; Walker U.A.. Arthritis Research and Therapy. 2019.

Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis.

Friebus-Kardash J; Trendelenburg M; Eisenberger U; Ribi C; Chizzolini C; Huynh-Do U; Lang KS; Wilde B; Kribben A; Witzke O; Dolff S; Hardt C. BMC Nephrology. 2019.

Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.

Nehring J; Schirmbeck LA; Friebus-Kardash J; Dubler D; Huynh-Do U; Chizzolini C; Ribi C; Trendelenburg M. Frontiers in Immunology. 2018.

Complement activation products in acute heart failure: Potential role in pathophysiology, responses to treatment and impacts on long-term survival.

Trendelenburg M; Stallone F; Pershyna K; Eisenhut T; Twerenbold R; Wildi K; Dubler D; Schirmbeck L; Puelacher C; Rubini Gimenez M; Sabti Z; Osswald L; Breidthardt T; Müller C. European heart journal. Acute cardiovascular care. 2018.

Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus.

Friebus-Kardash J; Branco L; Ribi C; Chizzolini C; Huynh-Do U; Dubler D; Roux-Lombard P; Dolff S; Kribben A; Eisenberger U; Trendelenburg M. Nephrology Dialysis Transplantation. 2018.

Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus.

Marchetti T; Ribi C; Perneger T; Trendelenburg M; Huynh-Do U; de Moerloose P; Chizzolini C. Rheumatology (Oxford, England). 2018.

Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.

Dahdal S; Devetzis V; Chalikias G; Tziakas D; Chizzolini C; Ribi C; Trendelenburg M; Eisenberger U; Hauser T; Pasch A; Huynh-Do U; Arampatzis S; Swiss Systemic Lupus Erythematosus Cohort Study Group.. PLoS One. 2018.

The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography.

Burkard T; Trendelenburg M; Daikeler T; Hess C; Bremerich J; Haaf P; Buser P; Zellweger MJ. PLoS One. 2018.

The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus.

Troldborg A; Thiel S; Trendelenburg M; Friebus-Kardash J; Nehring J; Steffensen R; Hansen SWK; Laska MJ; Deleuran B; Jensenius JC; Voss A; Stengaard-Pedersen K. The Journal of rheumatology. 2018.

The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury-Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor.

Panagiotou A; Trendelenburg M; Osthoff M. Frontiers in Immunology. 2018.

[Abdominal pain and hypertension in a 55-year-old male patient].

Kofler T; Yueksel F; Dirnhofer S; Donath MY; Trendelenburg M. Der Internist. 2017.

Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages.

Thanei S; Trendelenburg M. Journal of Leukocyte Biology. 2017.

Association of Lectin Pathway Protein Levels and Genetic Variants Early after Injury with Outcomes after Severe Traumatic Brain Injury: A Prospective Cohort Study.

Osthoff M; Walder B; Delhumeau C; Trendelenburg M; Turck N. Journal of neurotrauma. 2017.

Cathepsin S inhibition suppresses autoimmune-triggered inflammatory responses in macrophages.

Thanei S; Theron M; Silva AP; Reis B; Branco L; Schirmbeck L; Kolb FA; Haap W; Schindler T; Trendelenburg M. Biochemical pharmacology. 2017.

Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).

Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C; Swiss Systemic Lupus Erythematosus Cohort Study Group.. BMC IMMUNOLOGY. 2017.

Primary intestinal lymphangiectasia in an elderly female patient: A case report on a rare cause of secondary immunodeficiency.

Huber X; Degen L; Muenst S; Trendelenburg M. Medicine. 2017.

Anti-C1q autoantibodies are linked to autoimmune thyroid disorders in pregnant women

Vitkova H.; Jiskra J.; Springer D.; Limanova Z.; Telicka Z.; Bartakova J.; Trendelenburg M.; Potlukova E.. Clinical and experimental immunology. 2016.

Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in Macrophages.

Thanei S; Trendelenburg M. Journal of immunology (Baltimore, Md. : 1950). 2016.

Association of lectin pathway proteins with intra-abdominal Candida infection in high-risk surgical intensive-care unit patients. A prospective cohort study within the fungal infection network of Switzerland

Osthoff M.; Wojtowicz A.; Tissot F.; Jorgensen C.; Thiel S.; Zimmerli S.; Marchetti O.; Khanna N.; Bochud P.-Y.; Trendelenburg M.; Bregenzer T.; Conen A.; Fankhauser H.; Fluckiger U.; Frei R.; Heininger U.; Hertel R.; Franciolli M.; Dolina M.; Rothen M.; Dubuis O.; Tarr P.; Graf S.; Fleisch F.; Risch M.; Ritzler E.; Chuard C.; Erard V.; Fracheboud D.; Emonet S.; Genne D.; Lienhardt R.; Chave J.-P.; Andreutti-Zaugg C.; Gallusser A.; Graber P.; Monotti R.; Bernasconi E.; Krause M.; Herzog K.; Piso R.-J.; Schibli U.; Bally F.; Troillet N.; Tissiere L.; Boggian K.; Bruderer T.; Gubler J.; Eich G.; Berger C.. The Journal of infection. 2016.

Von Willebrand Factor Interacts with Surface-Bound C1q and Induces Platelet Rolling.

Kölm R; Schaller M; Roumenina LT; Niemiec I; Kremer Hovinga JA; Khanicheh E; Kaufmann BA; Hopfer H; Trendelenburg M. Journal of immunology (Baltimore, Md. : 1950). 2016.

Anti-C1q antibodies as a follow-up marker in SLE patients.

Bock M; Heijnen I; Trendelenburg M. PLoS One. 2015.

Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.

Thanei S; Vanhecke D; Trendelenburg M. Clinical Immunology. 2015.

Clinical presentation of human C1q deficiency: How much of a lupus?

Stegert M; Bock M; Trendelenburg M. Molecular immunology. 2015.

Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study.

Mandal J; Malla B; Steffensen R; Costa L; Egli A; Trendelenburg M; Blasi F; Kostikas K; Welte T; Torres A; Louis R; Boersma W; Milenkovic B; Aerts J; Rohde GG; Lacoma A; Rentsch K; Roth M; Tamm M; Stolz D. Respiratory research. 2015.

Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: A cross-sectional study of two cohorts

Koenig K.F.; Ribi C.; Radosavac M.; Zulewski H.; Trendelenburg M.. LUPUS. 2015.

Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up.

Pesickova SS; Rysava R; Lenicek M; Vitek L; Potlukova E; Hruskova Z; Jancova E; Honsova E; Zavada J; Trendelenburg M; Tesar V. Arthritis research & therapy. 2015.

Complement activation in patients with neuromyelitis optica.

Nytrova P; Potlukova E; Kemlink D; Woodhall M; Horakova D; Waters P; Havrdova E; Zivorova D; Vincent A; Trendelenburg M. Journal of neuroimmunology. 2014.

Cryoglobulinemia and chronic HCV infection: An evolving story

Schifferli J.A.; Trendelenburg M.. . 2014.

The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.

Ribi C; Trendelenburg M; Gayet-Ageron A; Cohen C; Dayer E; Eisenberger U; Hauser T; Hunziker T; Leimgruber A; Lindner G; Koenig K; Otto P; Spertini F; Stoll T; Von Kempis J; Chizzolini C; Swiss Systemic Lupus Erythematosus Cohort Study Group.. Swiss Medical Weekly. 2014.

Association between low levels of Mannan-binding lectin and markers of autoimmune thyroid disease in pregnancy.

Potlukova E; Freiberger T; Limanova Z; Jiskra J; Telicka Z; Bartakova J; Springer D; Vitkova H; Trendelenburg M. PLoS One. 2013.

Critical incidents in a tertiary care clinic for internal medicine.

Scharein P; Trendelenburg M. BMC research notes. 2013.

Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction.

Osthoff M; Trendelenburg M. BioMed research international. 2013.

Low levels of mannan-binding lectin or ficolins are not associated with an increased risk of cytomegalovirus disease in HIV-infected patients.

Egli A; Schäfer J; Osthoff M; Thiel S; Mikkelsen C; Rauch A; Hirsch HH; Bucher HC; Young J; Jensenius JC; Battegay M; Trendelenburg M; Swiss HIV Cohort Study.. PLoS One. 2013.

Anti-C1q antibodies as a diagnostic marker of proliferative lupus nephritis: comment on the article by Katsumata et al.

Trendelenburg M. Arthritis and rheumatism. 2012.

A trial of complement inhibition in a patient with cryoglobulin-induced glomerulonephritis.

Hirt-Minkowski P; Trendelenburg M; Gröschl I; Fischer A; Heijnen I; Schifferli JA. Case Rep Nephrol Urol. 2012.

Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay

Vanhecke D.; Roumenina L.T.; Wan H.; Osthoff M.; Schaller M.; Trendelenburg M.. Arthritis and rheumatism. 2012.

Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial.

Osthoff M; Piezzi V; Klima T; Christ A; Marana I; Hartwiger S; Breidthardt T; Marenzi G; Trendelenburg M; Mueller C. BMC Nephrology. 2012.

MBL serum levels in patients with sepsis correlate with thyroid function but not with outcome

Koenig K.F.; Potlukova E.; Mueller B.; Christ-Crain M.; Trendelenburg M.. Clinical Immunology. 2012.

Serum cytokine profile in patients with active lupus nephritis.

Koenig KF; Groeschl I; Pesickova SS; Tesar V; Eisenberger U; Trendelenburg M. Cytokine. 2012.

The complement system in cryoglobulinemia

Trendelenburg M.. . 2012.

Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis

Bigler, Cornelia; Hopfer, Helmut; Danner, Doris; Schaller, Monica; Mihatsch, Michael J.; Trendelenburg, Marten. Nephrology Dialysis Transplantation. 2011.

Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients

Osthoff M.; Katan M.; Fluri F.; Schuetz P.; Bingisser R.; Kappos L.; Steck A.J.; Engelter S.T.; Mueller B.; Christ-Crain M.; Trendelenburg M.. PLoS One. 2011.

Mannose-binding lectin - The forgotten molecule?

Osthoff M.; Trendelenburg G.; Eisen D.P.; Trendelenburg M.. Nature medicine. 2011.

Three cases of primary small vessel vasculitis of the skeletal muscle-an own entity.

Benz N; Daikeler T; Frank S; Mehling M; Tyndall A; Trendelenburg M. BMJ case reports. 2011.

A patient with SLE-associated thrombotic microangiopathy and non-neutralizing antibodies against ADAMTS13.

Knecht ME; Mayr M; Ferrari S; Scheiflinger F; Trendelenburg M. Nephrology Dialysis Transplantation. 2010.

Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation.

Nazarenko I; Rana S; Baumann A; McAlear J; Hellwig A; Trendelenburg M; Lochnit G; Preissner KT; Zöller M. Cancer research. 2010.

FRET imaging of cells transfected with siRNA/liposome complexes.

Kim IH; Järve A; Hirsch M; Fischer R; Trendelenburg MF; Massing U; Rohr K; Helm M. Methods in molecular biology (Clifton, N.J.). 2010.

Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Trendelenburg M; Theroux P; Stebbins A; Granger C; Armstrong P; Pfisterer M. European heart journal. 2010.

Mannose-binding lectin levels and major infections in a cohort of very long-term survivors after allogeneic stem cell transplantation.

Osthoff M; Rovó A; Stern M; Danner D; Gratwohl A; Tichelli A; Trendelenburg M. Haematologica. 2010.

Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis.

Vetter M; Battegay M; Trendelenburg M. Infection. 2010.

The production of mannan-binding lectin is dependent upon thyroid hormones regardless of the genotype: a cohort study of 95 patients with autoimmune thyroid disorders.

Potlukova E; Jiskra J; Freiberger T; Limanova Z; Zivorova D; Malickova K; Springer D; Grodecka L; Antosova M; Telicka Z; Pesickova SS; Trendelenburg M. Clinical Immunology. 2010.

[Towards the Swiss systemic lupus erythematosus cohort study (SSCS)].

Chizzolini C; Cohen CD; Eisenberger U; Hauser T; Hunziker T; Leimgruber A; Pechula M; Ribi C; Stoll T; Trendelenburg M; Groupe de travail de la SSCS.. Revue Medicale Suisse. 2009.

Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven.

Schaller M; Bigler C; Danner D; Ditzel HJ; Trendelenburg M. Journal of immunology (Baltimore, Md. : 1950). 2009.

Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.

Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M. Journal of immunology (Baltimore, Md. : 1950). 2009.

[Cryoglobulinemia].

Ottl T; Trendelenburg M. Therapeutische Umschau. Revue therapeutique. 2008.

[Successful treatment of thrombotic thrombocytopenic purpura (TTP) with rituximab].

Arici B; Trendelenburg M. Therapeutische Umschau. Revue therapeutique. 2008.

Antinucleosome antibodies as a marker of active proliferative lupus nephritis.

Bigler C; Lopez-Trascasa M; Potlukova E; Moll S; Danner D; Schaller M; Trendelenburg M. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2008.

Autoantibodies against complement C1q correlate with the thyroid function in patients with autoimmune thyroid disease.

Potlukova E; Jiskra J; Limanova Z; Kralikova P; Smutek D; Mareckova H; Antosova M; Trendelenburg M. Clinical and experimental immunology. 2008.

Autoantibodies against complement C1q in acute post-streptococcal glomerulonephritis.

Kozyro I; Korosteleva L; Chernoshej D; Danner D; Sukalo A; Trendelenburg M. Clinical Immunology. 2008.

From smolder to blaze - Pathogenesis and mechanisms of inflammation Vom glimmen zur glut - Pathogenese und mechanismen entzündlicher prozesse

Trendelenburg M.. Aktuelle Ernahrungsmedizin. 2008.

Successful treatment of thrombotic thrombocytopenic purpura (TTP) with Rituximab Erfolgreiche behandlung einer thrombotisch thrombozytopenischen purpura mit rituximab

Arici B.; Trendelenburg M.. Therapeutische Umschau. Revue therapeutique. 2008.

[Autoantibodies--physiological phenomenon or manifestation of disease?].

Trendelenburg M. Praxis. 2007.

Acute liver failure in two patients with regular alcohol consumption ingesting paracetamol at therapeutic dosage.

Krähenbuhl S; Brauchli Y; Kummer O; Bodmer M; Trendelenburg M; Drewe J; Haschke M. DIGESTION. 2007.

Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation.

Manuel O; Pascual M; Trendelenburg M; Meylan PR. Transplantation. 2007.

Complement inhibition by anti-C5 antibodies - From bench to bedside and back again

Trendelenburg M.. Swiss Medical Weekly. 2007.

Complement inhibition by anti-C5 antibodies--from bench to bedside and back again.

Trendelenburg M. Swiss Medical Weekly. 2007.

Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiency.

Manuel O; Tarr PE; Venetz JP; Trendelenburg M; Meylan PR; Pascual M. Transplant Infectious Disease. 2007.

Rituximab in a patient with Hyper-IgE syndrome.

Trendelenburg M; Schifferli JA. Archives of dermatology. 2007.

[Combined-heterozygous deficiency of complement C7 in a patient with recurrent meningitis].

Schirinzi R; Lantin JP; Frémeaux-Bacchi V; Schifferli JA; Trendelenburg M. Medizinische Klinik. 2006.

Clinical value of autoantibodies against C1q in children with glomerulonephritis

Kozyro I.; Perahud I.; Sadallah S.; Sukalo A.; Titov L.; Schifferli J.; Trendelenburg M.. Pediatrics. 2006.

High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.

Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J. Nephrology Dialysis Transplantation. 2006.

[Pathogenesis of systemic lupus erythematosus (SLE)--the central role of complement].

Trendelenburg M. Therapeutische Umschau. Revue therapeutique. 2005.

[Rheumatoid arthritis (RA) and systemic lupus erythematosus(SLE)].

Trendelenburg M; Schifferli J. Therapeutische Umschau. Revue therapeutique. 2005.

Antibodies against C1q in patients with systemic lupus erythematosus.

Trendelenburg M. SPRINGER SEMIN IMMUN. 2005.

The role of complement in cryoglobulin-induced immune complex glomerulonephritis.

Trendelenburg M; Fossati-Jimack L; Cortes-Hernandez J; Turnberg D; Lewis M; Izui S; Cook HT; Botto M. Journal of immunology (Baltimore, Md. : 1950). 2005.

Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice.

Trendelenburg M; Manderson AP; Fossati-Jimack L; Walport MJ; Botto M. Immunology. 2004.

Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients

Sadallah S.; Hess C.; Trendelenburg M.; Vedeler C.; Lopez-Trascasa M.; Schifferli J.A.. Clinical and experimental immunology. 2003.

Cryoglobulin/albumin complexes in a patient with severe autoimmune syndrome.

Trendelenburg M; Lutz HU; Tissot JD; Moll S; Hoffmann T; Schifferli JA. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2003.

Cryoglobulins in chronic hepatitis C virus infection.

Trendelenburg M; Schifferli JA. Clinical and experimental immunology. 2003.

Altered immunity syndrome, a distinct entity in long-term bone marrow transplantation survivors?

Trendelenburg,M; Gregor,M; Passweg,J; Tichelli,A; Tyndall,A; Gratwohl,A. Bone Marrow Transplantation. 2002.

"Altered immunity syndrome", a distinct entity in long-term bone marrow transplantation survivors?

Trendelenburg M; Gregor M; Passweg J; Tichelli A; Tyndall A; Gratwohl A. Bone Marrow Transplantation. 2001.

Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis.

Moroni G; Trendelenburg M; Del Papa N; Quaglini S; Raschi E; Panzeri P; Testoni C; Tincani A; Banfi G; Balestrieri G; Schifferli JA; Meroni PL; Ponticelli C. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2001.

Disseminated scabies evolving in a patient undergoing induction chemotherapy for acute myeloblastic leukaemia.

Trendelenburg M; Büchner S; Passweg J; Rätz Bravo AR; Gratwohl A. Annals of Hematology. 2001.

[Apoptosis and C1q: possible explanations for the pathogenesis of systemic lupus erythematosus].

Trendelenburg M; Schifferli JA. ZEITSCHRIFT FUR RHEUMATOLOGIE. 2000.

[New physiopathological findings in paraproteinemias].

Trendelenburg M; Schifferli JA. Schweizerische medizinische Wochenschrift. 2000.

Hepatitis virus-related and ethanol-induced chronic liver disease with or without cryoglobulins - Is there a difference concerning clinical or laboratory manifestation?

Breitschwerdt B.; Goeser T.; Tissot J.D.; Trendelenburg M.; Sis-Kluzik J.M.; Andrassy K.. Infection. 1999.

Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus?

Trendelenburg M; Courvoisier S; Späth PJ; Moll S; Mihatsch M; Itin P; Schifferli JA. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1999.

Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients.

Trendelenburg M; Marfurt J; Gerber I; Tyndall A; Schifferli JA. Arthritis and rheumatism. 1999.

Monomeric complement-activating IgG paraproteins.

Trendelenburg M; Hess C; Kondo-Oestreicher M; Tissot JD; Späth P; Schifferli JA. Journal of immunology (Baltimore, Md. : 1950). 1999.

[Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example].

Trendelenburg M; Schifferli JA. Praxis. 1998.

Are measurements of autoantibodies useful in patients with systemic lupus erythematosus? Anti-C1q as an example Sind autoantikörperbestimmungen bei patienten mit systemischem lupus erythematodes hilfreich? Anti-C1q-autoantikörper als beispiel

Trendelenburg M.; Schifferli J.A.. Praxis. 1998.

Correction of spurious blood cell counts in a patient with cryoglobulinemia reversed by the use of citrate-anticoagulated blood.

Infanti L; Spengeler V; Hoffmann T; Favre G; Passweg J; Trendelenburg M; Tichelli A. Schweizerische medizinische Wochenschrift. 1998.

Cryoglobulins are not essential.

Trendelenburg M; Schifferli JA. Annals of the rheumatic diseases. 1998.